Cited by 6Alzheimer's disease research and treatmentsAdvanced Neuroimaging Techniques and ApplicationsNeuroinflammation and Neurodegeneration Mechanisms

Apolipoprotein ε4 exacerbates white matter impairment in a mouse model of Aβ amyloidosis by decreasing actively myelinating oligodendrocytes

Open access
Al‐Amin, Md Mamun, Kim, Byungwook, Karahan, Hande, Tate, Mason D., Walsh, Sam P., Puntambekar, Shweta S., Bissel, Stephanie J., Lamb, Bruce T. +2 more·2025·Alzheimer's & Dementia

Abstract

INTRODUCTION: The ε4 allele of the apolipoprotein E ( APOE ) gene is a risk factor for the development of Alzheimer's disease (AD). APOE4 isoform is associated with increased white matter lesions in humans. To identify the underlying mechanisms of white matter impairment associated with APOE4 , we investigated the effects of APOE4 and APOE3 on multiple readouts of the white matter microstructural integrity. METHODS: Using magnetic resonance imaging and immunohistochemistry approaches, we analyzed white matter tracts in 5xFAD mice expressing APOE3 (5xFAD; APOE3 ) or APOE4 (5xFAD; APOE4 ). RESULTS: APOE4 significantly decreased fractional anisotropy, axial diffusivity, and neurite density index, while increasing radial diffusivity and isotropic volume fraction within major white matter tracts. Myelination was reduced in the corpus callosum of 5xFAD; APOE4 mice. Mechanistically, APOE4 reduced populations of mature and actively myelinating oligodendrocytes. DISCUSSION: Our results suggest that a decrease in the number of actively myelinating oligodendrocytes may explain myelin loss, leading to white matter impairments. Highlights: A robust neurite orientation dispersion and density imaging (NODDI) approach to study the effect of apolipoprotein E (APOE) isoforms on the white matter in 5xFAD mice. APOE4 reduces neurite density and increases water accumulation in the white matter. APOE4 disrupts structural connectivity and reduces the betweenness centrality. APOE4 decreases the number of actively myelinating oligodendrocytes. A reduction in myelinating oligodendrocyte populations may lead to myelin loss.

AI snapshot

Written from the paper’s full text.

TL;DR

In 5xFAD mice expressing human APOE3 or APOE4, APOE4 worsened white matter microstructure and structural connectivity, with reduced myelination in the corpus callosum. This was linked to fewer mature and actively myelinating oligodendrocytes, suggesting an oligodendrocyte-dependent mechanism for APOE4-associated white matter impairment.

Key findings

  • APOE4 reduced fractional anisotropy in the corpus callosum (t₂₀ = 2.82, p = 0.010) and hippocampal commissure (t₂₀ = 2.17, p = 0.048), but not anterior commissure (t₂₀ = 1.20, p = 0.242).
  • APOE4 increased radial diffusivity in corpus callosum (t₂₀ = 2.36, p = 0.028) and hippocampal commissure (t₂₀ = 2.14, p = 0.045), and increased isotropic volume fraction in corpus callosum (t₂₀ = 3.26, p = 0.003), hippocampal commissure (t₂₀ = 2.28, p = 0.034), and anterior commissure (t₂₀ = 2.18, p = 0.040).
  • APOE4 reduced neurite density index in corpus callosum (t₂₀ = 2.38, p = 0.028), hippocampal commissure (t₂₀ = 2.31, p = 0.034), and anterior commissure (t₂₀ = 2.44, p = 0.024), while orientation dispersion index was unchanged.
  • In corpus callosum, APOE4 reduced LFB intensity (t₉ = 3.85, p = 0.003) and MBP-positive area (t₉ = 2.86, p = 0.018), reduced CC1-positive mature oligodendrocytes (t₉ = 2.50, p = 0.033) and BCAS1-positive actively myelinating oligodendrocytes (t₉ = 12.12, p = 0.0001), without changing OLIG2-positive oligodendrocyte lineage cells (t₉ = 1.01, p = 0.340).

Methods

  • Male and female 5xFAD;APOE3 and 5xFAD;APOE4 mice were studied at 12–13 months: 23 mice total (12 APOE3, 11 APOE4); MRI analysis used 11 mice/genotype after excluding one APOE3 female for motion/noise artifacts.
  • In vivo structural and diffusion MRI at 9.4T included T2-weighted imaging, diffusion tensor metrics, NODDI metrics, seed-based tractography for corpus callosum, hippocampal commissure, and anterior commissure, and whole-brain structural connectome/network analysis.
  • Histology on a second cohort (6 APOE3, 5 APOE4) used Luxol fast blue, MBP, OLIG2, CC1, BCAS1, IBA1, and X-34 staining, with unpaired t-tests and correlation analyses between MRI metrics and histological markers.

Limitations

  • Stated: the cross-sectional design could not identify the exact onset of white matter changes; myelin content was not measured biochemically (e.g., western blotting) because of difficulty isolating pure white matter; and independent APOE3/APOE4 effects apart from 5xFAD-driven amyloid pathology were not examined.
  • Evident from the text: histological analyses used a smaller subset (n = 6 APOE3, n = 5 APOE4), and the study used mixed-sex groups with uneven sex distribution, without reporting sex-based analyses for most outcomes.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1002/alz.70791

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

37 of 49 cited sources checked · 8 supported · 2 flagged · accuracy not yet measured

  • Premisecitation

    Previous studies have not combined MRI and histological investigation within the same subjects.

    “Notably, previous studies have not combined MRI and histological investigation within the same subjects. 12 , 22 , 26 , 27”
    Quote in the paperSubstantial claim3 of 3 sources checked
    • cites [12] Sun J, Zhu Z, Chen K, et al. APOE ε4 allele accelerates age‐related multi‐cognitive decline and white matter damage in non‐demented elderly. Aging (Albany NY). 2020; 12: 12019‐ 12031. 32572010 PMC7343443 source

      The Materials and Methods sections on MRI data acquisition and participants describe MRI scans and blood samples for genotyping, but do not discuss histological investigation. Searches for histology combined with MRI in the same subjects found no passage assessing whether previous studies had done so. (LLM, conf=0.74)

      Experimental — accuracy not yet measured
    • cites [22] Mirza SS, Saeed U, Knight J, et al. APOE ε4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia. Neurology. 2019; 93: e1807‐ e1819. 31575706 PMC6946485 source

      The Methods describe MRI measurements in the Sunnybrook Dementia Study (SDS) sample and postmortem neuropathologic examination of 36 SDS cases. The Discussion also identifies an autopsy-confirmed subset. This cited study therefore combined MRI and histological investigation in some of the same subjects, contrary to the claim that previous studies had not done so. (LLM, conf=0.86)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
    • cites [26] Mok KK, Yeung SH, Cheng GW, et al. Apolipoprotein E ε4 disrupts oligodendrocyte differentiation by interfering with astrocyte‐derived lipid transport. J Neurochem. 2023; 165: 55‐ 75. 36549843 source

      The Brightfield Immunohistochemistry and Immunohistochemistry-Immunofluorescence methods sections describe histological imaging of mouse brain tissue. Searches for MRI combined with histology in the same subjects found no passage discussing whether previous studies had done so; the claim cannot be verified from our copy. (LLM, conf=0.73)

      Experimental — accuracy not yet measured
  • Premisecitation

    Multiple MRI studies have reported that the APOE4 isoform is associated with white matter degeneration in patients with dementia.

    “Multiple MRI studies have reported that APOE4 isoform is associated with white matter degeneration in patients with dementia. 10 , 11 , 22 , 23”
    Quote in the paperNot a substantial claim2 of 3 sources checked
    • cites [10] Kumar D, Yatawara C, Wang B, et al. APOE4 and confluent white matter hyperintensities have a synergistic effect on episodic memory impairment in prodromal dementia. J Alzheimers Dis. 2022; 87: 1103‐ 1114. 35431245 source
    • cites [11] Vipin A, Kumar D, Soo SA, et al. APOE4 carrier status determines association between white matter disease and grey matter atrophy in early‐stage dementia. Alzheimers Res Ther. 2023; 15: 103. 37270543 PMC10239168 source

      The Introduction reports prior associations between APOE4 and white matter hyperintensity burden, an MRI marker of white matter disease, but says findings on APOE4’s influence on that burden are mixed. It does not establish that multiple MRI studies found white matter degeneration specifically in patients with dementia; the Discussion also reports no difference in hyperintensity load between carriers and non-carriers in this study. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [22] Mirza SS, Saeed U, Knight J, et al. APOE ε4, white matter hyperintensities, and cognition in Alzheimer and Lewy body dementia. Neurology. 2019; 93: e1807‐ e1819. 31575706 PMC6946485 source

      The Discussion reports faster MRI-visible white matter hyperintensity progression in APOE ε4–positive patients with Alzheimer disease, supporting an association in that group. But this paper’s own MRI analyses primarily examine how APOE ε4 modifies the relationship between white matter hyperintensities and cognition in Alzheimer and Lewy body dementia; the Results also report lower hyperintensity volume in homozygous carriers than in other groups. It therefore does not establish the claimed general association between APOE4 and white matter degeneration across patients with dementia. (LLM, conf=0.83)

      Experimental — accuracy not yet measured
  • Premisecitation

    Even cognitively normal elderly APOE4 carriers exhibit an accelerated decline in white matter integrity.

    “Even cognitively normal elderly APOE4 carriers also exhibit an accelerated decline in white matter integrity. 12”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [12] Sun J, Zhu Z, Chen K, et al. APOE ε4 allele accelerates age‐related multi‐cognitive decline and white matter damage in non‐demented elderly. Aging (Albany NY). 2020; 12: 12019‐ 12031. 32572010 PMC7343443 source

      The Abstract and Discussion report an accelerated age-related reduction in white matter integrity among APOE ε4 carriers compared with noncarriers. However, the Methods define the participants as non-demented, not necessarily cognitively normal, and the Results include participants with mild cognitive impairment. The claim therefore overstates the population studied. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Premisecitation

    Myelin maintenance in white matter is actively regulated by the continuous proliferation and maturation of oligodendrocytes derived from progenitor cells throughout adulthood.

    “Myelin maintenance in white matter is actively regulated by the continuous proliferation and maturation of oligodendrocytes derived from progenitor cells throughout adulthood. 24 , 25”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites [24] Young KM, Psachoulia K, Tripathi RB, et al. Oligodendrocyte dynamics in the healthy adult CNS: evidence for myelin remodeling. Neuron. 2013; 77: 873‐ 885. 23473318 PMC3842597 source

      The Introduction (page not provided) reports that oligodendrocyte precursors continue dividing into adulthood and that some newly formed oligodendrocytes form myelin. The Discussion (page not provided) presents maintenance of existing myelin as a possibility, not an established function of this process throughout white matter; it also considers myelination of previously unmyelinated axons. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
    • cites [25] Fard MK, van der Meer F, Sánchez P, et al. BCAS1 expression defines a population of early myelinating oligodendrocytes in multiple sclerosis lesions. Sci Transl Med. 2017; 9: eaam7816. 29212715 PMC7116798 source

      The Introduction says adult mouse progenitor cells continuously generate oligodendrocytes and that myelination continues into adulthood. But the Results find that early myelinating cells in human white matter become scarce after childhood, while another Results section finds no extensive turnover of myelinating oligodendrocytes in adult mice. The paper therefore does not establish continuous progenitor-derived oligodendrocyte maturation as the mechanism of white-matter myelin maintenance throughout adulthood. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Premisecitation

    NODDI provides enhanced sensitivity and specific metrics for detecting Alzheimer's disease-associated microstructural changes.

    “In contrast, NODDI provides enhanced sensitivity and specific metrics for detecting AD‐associated microstructural changes. 31 , 32 , 33”
    Quote in the paperSubstantial claim3 of 3 sources checked
    • cites [31] Raghavan S, Reid RI, Przybelski SA, et al. Diffusion models reveal white matter microstructural changes with ageing, pathology and cognition. Brain Commun. 2021; 3: fcab106. 34136811 PMC8202149 source

      The Discussion (page not provided) reports that NODDI metrics detected Alzheimer’s disease–related white-matter changes and offered more detailed information about neurite health. It does not establish enhanced detection sensitivity over DTI: the Introduction frames that as a hypothesis, and the Discussion says both methods detected subtle Alzheimer’s disease–related changes. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [32] Yu X, Przybelski SA, Reid RI, et al. NODDI in gray matter is a sensitive marker of aging and early AD changes. Alzheimers Dement. 2024; 16: e12627. PMC11284641 39077685 source
    • cites [33] Colon‐Perez LM, Ibanez KR, Suarez M, et al. Neurite orientation dispersion and density imaging reveals white matter and hippocampal microstructure changes produced by Interleukin‐6 in the TgCRND8 mouse model of amyloidosis. Neuroimage. 2019; 202: 116138. 31472250 PMC6894485 source

      The Introduction (page not available in our copy) says NODDI provides metrics of axonal and dendritic dispersion and density and reports changes in young-onset Alzheimer’s disease. The Discussion reports changes in those metrics in an amyloidosis mouse model. These passages support the specific-metrics and detection portions of the claim, but do not establish enhanced sensitivity relative to another method. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
  • Classified as probably not a substantial claim. 19
  • May combine two claims. 21
  • The quote only partly states this claim. 1
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Tau and amyloid-beta deposition contribute to the loss of white matter integrity.

    “it is thought that tau and Aβ deposition contribute to the loss of white matter integrity. 16 , 17 , 18”
    Quote in the paperNot a substantial claim3 of 3 sources checked
    • cites [16] Magalhães TNC, Casseb RF, Gerbelli CLB, et al. Whole‐brain DTI parameters associated with tau protein and hippocampal volume in Alzheimer's disease. Brain Behav. 2023; 13: e2863. 36601694 PMC9927845 source
    • cites [17] Strain JF, Smith RX, Beaumont H, et al. Loss of white matter integrity reflects tau accumulation in Alzheimer disease defined regions. Neurology. 2018; 91: e313‐ e318. 29959265 PMC6070383 source

      The Conclusion states that tau, not Aβ, was associated with changes in anterior temporal white-matter integrity. The Results likewise report that tau predicted an integrity measure in certain tracts, while amyloid failed to predict either measure in any summary tract. Thus, the paper supports the tau portion but makes a contrary finding for Aβ. (LLM, conf=0.89)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
    • cites [18] Tian J, Raghavan S, Reid RI, et al. White matter degeneration pathways associated with tau deposition in Alzheimer disease. Neurology. 2023; 100: e2269‐ e2278. 37068958 PMC10259272 source

      The Discussion (page not provided) reports that declining white matter integrity was associated with increased tau deposition in Alzheimer disease. It does not establish that amyloid-beta deposition also contributes to that decline; it says white matter integrity may be more correlated with tau than with Aβ. The reported tau finding is an association, not proof of causation. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    APOE4 is a well-established risk factor for Alzheimer's disease, increasing disease susceptibility compared with APOE3.

    “Conversely, APOE4 is a well‐established risk factor for AD, increasing disease susceptibility compared with APOE3. 5”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [5] Kim J, Basak JM, Holtzman DM. The role of apolipoprotein E in Alzheimer's disease. Neuron. 2009; 63: 287‐ 303. 19679070 PMC3044446 source
  • May combine two claims.

    Premisecitation

    APOE4 compromises the integrity of white matter, further disrupting brain connectivity and function.

    “Beyond its effects on gray matter, APOE4 also compromises the integrity of white matter, further disrupting brain connectivity and function. 10 , 11 , 12”
    Quote in the paperSubstantial claim2 of 3 sources checked
    • cites [10] Kumar D, Yatawara C, Wang B, et al. APOE4 and confluent white matter hyperintensities have a synergistic effect on episodic memory impairment in prodromal dementia. J Alzheimers Dis. 2022; 87: 1103‐ 1114. 35431245 source
    • cites [11] Vipin A, Kumar D, Soo SA, et al. APOE4 carrier status determines association between white matter disease and grey matter atrophy in early‐stage dementia. Alzheimers Res Ther. 2023; 15: 103. 37270543 PMC10239168 source

      The Discussion (page unavailable) suggests that APOE4-related blood–brain barrier disruption may contribute to white matter hyperintensities, but does not establish that APOE4 compromises white matter integrity. The Results (page unavailable) link greater white matter hyperintensity load to poorer cognition primarily in APOE4 non-carriers, and the paper does not show that APOE4 disrupts brain connectivity. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
    • cites [12] Sun J, Zhu Z, Chen K, et al. APOE ε4 allele accelerates age‐related multi‐cognitive decline and white matter damage in non‐demented elderly. Aging (Albany NY). 2020; 12: 12019‐ 12031. 32572010 PMC7343443 source

      The Abstract reports faster age-related loss of white-matter integrity in APOE ε4 carriers, and the Results report associations between white-matter integrity and cognitive performance in older carriers. The paper does not establish that this damage disrupts brain connectivity or causes impaired function; the Discussion presents a link to cognitive deficits as a possibility. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Voxel-based morphometry analysis used 5000 permutations and family-wise error correction.

    “We performed 5000 permutations and applied family‐wise error correction. 39”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [39] Bennett CM, Wolford GL, Miller MB. The principled control of false positives in neuroimaging. Soc Cogn Affect Neurosci. 2009; 4: 417‐ 422. 20042432 PMC2799957 source

      The ‘Techniques for principled correction’ section identifies permutation-based correction as a way to control family-wise error in neuroimaging. It does not specify 5000 permutations or describe a voxel-based morphometry analysis, so it cannot substantiate those details of the citing authors’ method. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning

    The fixation method was changed to paraformaldehyde combined with lysine and sodium metaperiodate for the second MRI cohort.

    “Therefore, we had to change our fixation method to paraformaldehyde combined with lysine and sodium metaperiodate 47 with our second MRI cohort, consisting of six 5xFAD;APOE3 and five 5xFAD;APOE4 mice.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites [47] Pfeiffer F, Sherafat A, Nishiyama A. The impact of fixation on the detection of oligodendrocyte precursor cell morphology and vascular associations. Cells. 2021; 10: 1302. 34073801 PMC8225113 source
  • Classified as probably not a substantial claim.

    Premisecitation

    Actively myelinating oligodendrocytes are responsible for the ongoing formation and repair of myelin during the demyelinating process observed in multiple sclerosis and multiple system atrophy.

    “Actively myelinating oligodendrocytes are responsible for the ongoing formation and repair of myelin during the demyelinating process observed in multiple sclerosis and multiple system atrophy. 29 , 30”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites [29] Kaji S, Maki T, Ueda J, et al. BCAS1‐positive immature oligodendrocytes are affected by the α‐synuclein‐induced pathology of multiple system atrophy. Acta Neuropathol Commun. 2020; 8: 120. 32727582 PMC7391509 source

      The Introduction identifies BCAS1-positive immature oligodendrocytes as present during active myelination and remyelination and reports their increase in remyelinating areas of multiple sclerosis. For multiple system atrophy, however, the Conclusions report impaired oligodendroglial maturation and regeneration, not successful ongoing myelin repair. Page numbers are not available in the supplied copy. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [30] Bergner CG, van der Meer F, Franz J, et al. BCAS1‐positive oligodendrocytes enable efficient cortical remyelination in multiple sclerosis. Brain. 2025; 148: 908‐ 920. 39319704 PMC11884765 source

      The Abstract and Discussion report that actively myelinating BCAS1-positive oligodendrocytes participate in cortical myelin repair in multiple sclerosis. The paper does not establish that they perform this role in multiple system atrophy; that condition appears in the title of a cited work in the References, which does not substantiate the repair claim. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Impaired white matter integrity is a hallmark of the early stage of Alzheimer's disease.

    “Impaired white matter integrity is a hallmark of the early stage of AD, 14 , 15”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites [14] Wen Q, Mustafi SM, Li J, et al. White matter alterations in early‐stage Alzheimer's disease: a tract‐specific study. Alzheimers Dement. 2019; 11: 576‐ 587. PMC6713788 31467968 source

      The Introduction (page unavailable) describes white matter degeneration in early AD, and the Discussion reports significant white matter alterations in participants with MCI. But the Discussion also reports no significant differences between the cognitively normal and subjective cognitive decline groups in this study. Calling impaired white matter integrity a hallmark of the early stage overstates the consistency of the paper’s findings. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
    • cites [15] Ahmadi K, Pereira JB, van Westen D, et al. Fixel‐based analysis reveals macrostructural white matter changes associated with tau pathology in early stages of Alzheimer's disease. medRxiv. 2023. 2023.02.17.23286094. source
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    White matter microstructural damage in Alzheimer's disease is associated with disrupted structural connectivity and impaired network functions.

    “This damage is associated with disrupted structural connectivity and impaired network functions. 19 , 20 , 21”
    Quote in the paperNot a substantial claim2 of 3 sources checked
    • cites [19] Chen Y, Wang Y, Song Z, Fan Y, Gao T, Tang X. Abnormal white matter changes in Alzheimer's disease based on diffusion tensor imaging: a systematic review. Ageing Res Rev. 2023; 87: 101911. 36931328 source
    • cites [20] Pereira JB, Mijalkov M, Kakaei E, et al. Disrupted network topology in patients with stable and progressive mild cognitive impairment and Alzheimer's disease. Cereb Cortex. 2016; 26: 3476‐ 3493. 27178195 PMC4961019 source

      The Discussion reports abnormal network organization in AD patients and interprets increased path length as less efficient communication between brain regions. But the Methods describe networks built from cortical thickness and subcortical volume, not measures of white-matter microstructural damage. The paper therefore supports disrupted network organization, but does not establish the claimed association with that damage or directly measure impaired network function. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites [21] He Y, Chen Z, Evans A. Structural insights into aberrant topological patterns of large‐scale cortical networks in Alzheimer's disease. J Neurosci. 2008; 28: 4756‐ 4766. 18448652 PMC6670444 source

      The Introduction (page unavailable) describes white-matter damage as a proposed cause of structural disconnection in Alzheimer’s disease. The Discussion reports disrupted cortical structural networks, but these were measured through cortical thickness, not white-matter microstructure; the section on structural and functional brain networks presents a link to functional impairment as speculation rather than a demonstrated association. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Microstructural damage in the white matter of Alzheimer's disease patients has been reported in the corpus callosum, fornix, and cingulum.

    “Microstructural damage in the white matter of AD patients has been reported in the corpus callosum, fornix, and cingulum. 19 , 20 , 21”
    Quote in the paperNot a substantial claim2 of 3 sources checked
    • cites [19] Chen Y, Wang Y, Song Z, Fan Y, Gao T, Tang X. Abnormal white matter changes in Alzheimer's disease based on diffusion tensor imaging: a systematic review. Ageing Res Rev. 2023; 87: 101911. 36931328 source
    • cites [20] Pereira JB, Mijalkov M, Kakaei E, et al. Disrupted network topology in patients with stable and progressive mild cognitive impairment and Alzheimer's disease. Cereb Cortex. 2016; 26: 3476‐ 3493. 27178195 PMC4961019 source

      The Discussion (page unavailable) says that white-matter integrity loss or disruption of white-matter fibers has previously been observed in MCI and AD patients. It does not locate that damage in the corpus callosum, fornix, and cingulum; the cited paper’s reference-list entry about cingulum imaging does not establish the full three-tract claim. (LLM, conf=0.83)

      Experimental — accuracy not yet measured
    • cites [21] He Y, Chen Z, Evans A. Structural insights into aberrant topological patterns of large‐scale cortical networks in Alzheimer's disease. J Neurosci. 2008; 28: 4756‐ 4766. 18448652 PMC6670444 source

      The Introduction reports evidence suggesting AD-related abnormalities in white-matter structural integrity in the corpus callosum and cingulum. It names the superior longitudinal fasciculus, not the fornix, as the third example. The paper does not report microstructural measurements of all three tracts. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    APOE4 is known to disrupt oligodendrocyte differentiation and contribute to myelin breakdown in mouse models without any Alzheimer's disease pathology.

    “APOE4 is known to disrupt oligodendrocyte differentiation and contribute to myelin breakdown in mouse models without any AD pathology. 26 , 27 , 28”
    Quote in the paperSubstantial claim3 of 3 sources checked
    • cites [26] Mok KK, Yeung SH, Cheng GW, et al. Apolipoprotein E ε4 disrupts oligodendrocyte differentiation by interfering with astrocyte‐derived lipid transport. J Neurochem. 2023; 165: 55‐ 75. 36549843 source

      The Discussion reports disrupted oligodendrocyte differentiation in a humanized APOE4 mouse model without amyloid-cascade transgenes; it also reports no neurodegeneration at 12 months. But it describes myelin breakdown as one possible explanation for the increased FluoroMyelin signal, not an established finding, and notes that such models can have AD-like phenotypes. Thus “myelin breakdown” and “without any AD pathology” overstate the evidence (Discussion; page unavailable). (LLM, conf=0.87)

      Experimental — accuracy not yet measured
    • cites [27] Cheng GW, Mok KK, Yeung SH, Kofler J, Herrup K, Tse KH. Apolipoprotein E ε4 mediates myelin breakdown by targeting oligodendrocytes in sporadic Alzheimer disease. J Neuropathol Exp Neurol. 2022; 81: 717‐ 730. 35779013 PMC9393713 source

      The Discussion reports reduced oligodendrocyte numbers in hAPOE4 mice without amyloid plaques, supporting an effect independent of that AD pathology. But the section “Human APOE Depletes OLs, but Not Myelin Fibers in the Aging Mouse Brain” reports unchanged myelinated area, and the Discussion describes impaired maintenance of oligodendrocytes rather than demonstrated disruption of their differentiation in mice. The claim of myelin breakdown in those mice is not supported. (LLM, conf=0.90)

      Experimental — accuracy not yet measured
    • cites [28] Blanchard JW, Akay LA, Davila‐Velderrain J, et al. APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. Nature. 2022; 611: 769‐ 779. 36385529 PMC9870060 source

      The Introduction reports fewer myelinated axons and thinner myelin sheaths in APOE4 targeted-replacement mice than in APOE3 mice. It does not establish that APOE4 disrupted oligodendrocyte differentiation or caused breakdown of existing myelin in those mice. The finding in individuals without AD pathology concerns human myelin-associated gene expression, not a documented absence of AD pathology in the mice. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • May combine two claims.

    Premisecitation

    BCAS1-positive oligodendrocytes serve as a marker for actively myelinating oligodendrocytes and are distinct from oligodendrocyte progenitor cells and mature oligodendrocytes.

    “BCAS1‐positive oligodendrocytes serve as a marker for these actively myelinating oligodendrocytes and are distinct from both oligodendrocyte progenitor cells and mature oligodendrocytes. 25”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites [25] Fard MK, van der Meer F, Sánchez P, et al. BCAS1 expression defines a population of early myelinating oligodendrocytes in multiple sclerosis lesions. Sci Transl Med. 2017; 9: eaam7816. 29212715 PMC7116798 source
  • May combine two claims.

    Findingown data

    5xFAD;APOE4 mice had significantly lower fractional anisotropy in the corpus callosum and hippocampal commissure than 5xFAD;APOE3 mice, but not in the anterior commissure.

    “Compared with 5xFAD;APOE3 mice, 5xFAD;APOE4 mice had a significant reduction in fractional anisotropy within the corpus callosum [t 20 = 2.82, p = 0.010] (Figure 2H) and hippocampal commissure [t 20 = 2.17, p = 0.048] (Figure 2I) but not in the anterior commissure [t 20 = 1.20, p = 0.242] (Figure 2J).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    5xFAD;APOE4 mice had significantly lower axial diffusivity in the corpus callosum and hippocampal commissure than 5xFAD;APOE3 mice, but not in the anterior commissure.

    “Additionally, tract‐based analysis revealed a significant reduction in axial diffusivity within the corpus callosum [t 20 = 2.50, p = 0.020] (Figure 2M) and the hippocampal commissure [t 20 = 2.42, p = 0.024] (Figure 2N) of 5xFAD;APOE4 mice, whereas the anterior commissure remained unaffected [t 20 = 0.01, p = 0.988] (Figure 2O).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    5xFAD;APOE4 mice had significantly higher radial diffusivity in the corpus callosum and hippocampal commissure than 5xFAD;APOE3 mice, but not in the anterior commissure.

    “Tract‐based analysis further revealed significantly higher radial diffusivity in the corpus callosum [t 20 = 2.36, p = 0.028] (Figure 2R) and hippocampal commissure [t 20 = 2.14, p = 0.045] (Figure 2S) of 5xFAD;APOE4 mice but not in the anterior commissure [t 20 = 1.61, p = 0.122] (Figure 2T).”
    Quote in the paperSubstantial claim
  • The quote only partly states this claim.

    Findingown data

    Betweenness centrality was significantly reduced in 5xFAD;APOE4 mice compared with 5xFAD;APOE3 mice (t20 = 2.85, p = 0.009).

    “However, we detected a significant reduction in betweenness centrality [t 20 = 2.85, p = 0.009] in 5xFAD;APOE4 mice (Figure 4E).”
    • Also stated in: § Biological interpretations of connectivity and network topology changes · plain
      “We identified a reduced betweenness centrality in 5xFAD;APOE4 mice (Figure 4E).”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning

    A reduced sparsity network (30%) was employed for graph theory analysis.

    “Given the probability of false connections arising from probabilistic tractography, we employed a reduced sparsity network (30%).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    Network-based statistics analysis used 5000 permutations within a threshold range of 2.5-3.5.

    “We performed 5000 permutations within a threshold range of 2.5–3.5.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    BCAS1 immunostaining failed in the first MRI cohort because paraformaldehyde fixation alone was insufficient for preserving BCAS1 antigenicity.

    “Unfortunately, BCAS1 immunostaining failed in the first MRI cohort. The fixation conditions with paraformaldehyde alone were insufficient for preserving the antigenicity of BCAS1.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    One female mouse from the 5xFAD;APOE3 group was excluded from MRI analysis due to severe motion and noise artifacts.

    “We excluded one female mouse from 5xFAD;APOE3 group due to the severe motion and noise artifacts.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    In Alzheimer's disease, damage to white matter is associated with impaired executive function and weakened memory performance.

    “In AD, damage to white matter has been associated with impaired executive function and weakened memory performance. 13”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [13] Kaskikallio A, Karrasch M, Koikkalainen J, et al. White matter hyperintensities and cognitive impairment in healthy and pathological aging: a quantified brain MRI study. Dement Geriatr Cogn Disord. 2019; 48: 297‐ 307. 32209796 source
  • May combine two claims.

    Interpretationown data

    Reductions in fractional anisotropy and axial diffusivity, coupled with increased radial diffusivity, indicate that APOE4 disrupted fiber tracts and demyelination selectively in the corpus callosum and hippocampal commissure.

    “Taken together, these reductions in fractional anisotropy and axial diffusivity, coupled with increased radial diffusivity, indicate APOE4 disrupted fiber tracts and demyelination selectively in the corpus callosum and hippocampal commissure.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Study design and conductown data

    The diffusion MRI protocol combining 116 directions across shells improved angular resolution for whole-brain structural connectivity mapping and reduced false-positive tracking errors compared to single-shell approaches.

    “Our protocol, combining 116 directions across shells, significantly improved angular resolution for whole brain structural connectivity mapping. Our protocol reduced false‐positive tracking errors compared to single shell approaches.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning

    MRI data were analyzed from 11 mice per genotype.

    “Therefore, we analyzed MRI data from 11 mice/genotype.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationown data

    APOE4 promotes axonal or dendritic loss but does not disrupt the overall structural orientation of the surviving fibers.

    “This result demonstrates that while APOE4 promotes axonal or dendritic loss, it does not disrupt the overall structural orientation of the surviving fibers, potentially preserving some aspects of tract function even as cellular density declines.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    A high-sensitivity cryogenically cooled radiofrequency surface receive-only coil was used to increase the signal-to-noise ratio.

    “A high‐sensitivity cryogenically cooled radiofrequency surface receive‐only coil (Bruker CryoProbe) was used to increase the signal‐to‐noise ratio.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    A 10% threshold was applied to eliminate spurious signals from probabilistic tractography.

    “The resulting tractograms were subsequently transformed into track‐density maps, and a 10% threshold was applied to eliminate spurious signals from the probabilistic tractography.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationown data

    The reduced betweenness centrality in 5xFAD;APOE4 mice indicates a diminished role of certain brain regions as critical hubs for information flow, potentially reflecting impaired integration and disrupted communication pathways within the neuronal network.

    “The reduced betweenness centrality in 5xFAD;APOE4 mice demonstrates a diminished role of certain brain regions as critical hubs for information flow, potentially reflecting impaired integration and disrupted communication pathways within the neuronal network.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    These microstructural alterations likely contribute to the observed impairment in white matter integrity and may reflect axonal loss, demyelination, and increased tissue water content.

    “These alterations likely contribute to the observed impairment in white matter integrity and may reflect underlying processes such as axonal loss, demyelination, and increased tissue water content.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Loss of axons and dendrites decreases the intraneurite space, reflected by a decrease in NDI.
    • Rests on an assumption: A reduction in NDI is often accompanied by expansion of the extraneurite space (higher ODI) or accumulation of cerebrospinal fluid (higher isotropic volume fraction).
  • May combine two claims.

    Premisecitation

    Demyelination or axonal damage reduces diffusion restriction, decreasing fractional anisotropy.

    “Demyelination or axonal damage reduces diffusion restriction, decreasing fractional anisotropy.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [51] Beaulieu C. The basis of anisotropic water diffusion in the nervous system—a technical review. NMR Biomed. 2002; 15: 435‐ 455. 12489094 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Two complementary staining methods were employed to assess myelination in the white matter.

    “However, we employed two complementary staining methods to assess myelination in the white matter.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationown data

    These alterations in connectivity and network topology in 5xFAD;APOE4 mice reveal regional network adaptations occurring in the presence of amyloid pathology, potentially driving synaptic dysfunctions in AD.

    “These alterations in connectivity and network topology in 5xFAD;APOE4 mice reveal regional network adaptations occurring in the presence of amyloid pathology, potentially driving synaptic dysfunctions in AD.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    APOE4 induces significant microstructural changes in white matter, including reduced neurite density and increased free water.

    “These findings collectively indicate that APOE4 induces significant microstructural changes in white matter, including reduced neurite density and increased free water.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: Loss of axons and dendrites decreases the intraneurite space, reflected by a decrease in NDI.
    • Rests on an assumption: A reduction in NDI is often accompanied by expansion of the extraneurite space (higher ODI) or accumulation of cerebrospinal fluid (higher isotropic volume fraction).
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Myelin loss is correlated with reduced fractional anisotropy in AD.

    “This finding is consistent with evidence that shows myelin loss is correlated with reduced fractional anisotropy in AD. 51”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [51] Beaulieu C. The basis of anisotropic water diffusion in the nervous system—a technical review. NMR Biomed. 2002; 15: 435‐ 455. 12489094 source
  • May combine two claims.

    Interpretationown data

    There is a selective loss of mature oligodendrocytes in 5xFAD;APOE4 mice, without global dysregulation of the total oligodendrocyte lineage cell population.

    “These data suggest that there is a selective loss of mature oligodendrocytes, although there was no global dysregulation of the total oligodendrocyte lineage cell population.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    APOE4 exacerbates amyloid-β deposition in myelinated regions such as the corpus callosum, which in turn may trigger pronounced microglial activation.

    “These findings suggest that APOE4 exacerbates amyloid‐β deposition in myelinated regions, such as the corpus callosum, which in turn may trigger pronounced microglial activation.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning

    The cross-sectional design precluded identification of the exact onset time for white matter integrity changes.

    “First, its cross‐sectional design precluded the identification of the exact onset time for white matter integrity changes.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationown data

    APOE4 protein may cause demyelination or impaired myelin maintenance.

    “Our data demonstrate that APOE4 protein may cause demyelination or impaired myelin maintenance.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    In 5xFAD;APOE4 mice, amyloid accumulation presumably exacerbates disruption of the tissue environment, damages neurites, contributing to elevated water content, further pointing to white matter impairment.

    “In 5xFAD;APOE4 mice, amyloid accumulation presumably exacerbates disruption of the tissue environment, damages neurites, contributing to elevated water content (Figure S4D), further pointing to white matter impairment through pathological processes.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationown data

    Amyloid accumulation is linked to microstructural alterations and changes in tissue microenvironment.

    “This result suggests that amyloid accumulation is linked to microstructural alterations and changes in tissue microenvironment.”
    Quote in the paperSubstantial claim
39 of 39
  • The paper relies on this without support.

    The 12–13 month time point represents an advanced stage of Alzheimer's-like pathology and functional decline in the 5xFAD model.

    “This time point represents advanced stage of Alzheimer's‐like pathology and functional decline in the 5xFAD model.”
  • The paper relies on this without support.

    The 5xFAD;APOE3 genotype is an appropriate control for isolating the effects of APOE4 in the context of amyloid deposition.

    “The resulting offspring, 5xFAD+/−;APOE3 +/+ and 5xFAD+/−;APOE4 +/+, served as models to study the effects of APOE isoforms in the context of amyloid deposition.”
  • The authors state this as an assumption.

    The NODDI model assumptions that neurites are impermeable sticks in a homogeneous background are valid for the brain tissues studied.

    “where neurites were considered impermeable sticks (cylinders with zero radius) in a homogeneous background.”
  • The paper relies on this without support.

    The mouse model of amyloid-beta amyloidosis is relevant to human Alzheimer's disease white matter impairment.

    “To identify the underlying mechanisms of white matter impairment associated with APOE4, we investigated the effects of APOE4 and APOE3 on multiple readouts of the white matter microstructural integrity.”
  • The paper relies on this without support.

    Higher radial diffusivity and isotropic volume fraction are associated with increased water content and reduced myelin integrity.

    “Higher radial diffusivity and isotropic volume fraction have been associated with increased water content and reduced myelin integrity.”
  • The paper relies on this without support.

    In healthy white matter, water diffuses primarily in the direction of myelinated axons.

    “In healthy white matter, water diffuses primarily in the direction of myelinated axons.”
  • The paper relies on this without support.

    Loss of axons and dendrites decreases the intraneurite space, reflected by a decrease in NDI.

    “Loss of axons and dendrites decreases the intraneurite space, as reflected by a decrease in the NDI.”
  • The paper relies on this without support.

    A reduction in NDI is often accompanied by expansion of the extraneurite space (higher ODI) or accumulation of cerebrospinal fluid (higher isotropic volume fraction).

    “This reduction is often accompanied by an expansion of the extraneurite space, indicated by a higher ODI, or by an accumulation of cerebrospinal fluid, indicated by a higher isotropic volume fraction.”
  • The paper relies on this without support.

    Mature oligodendrocytes are essential for the formation and maintenance of myelin sheaths around axons in the adult brain.

    “Mature oligodendrocytes are essential for the formation and maintenance of myelin sheaths around axons in the adult brain.”
  • The paper relies on this without support.

    The entorhinal cortex is crucial for spatial navigation and memory and is among the earliest regions affected in AD.

    “The entorhinal cortex, crucial for spatial navigation and memory, is among the earliest regions affected in AD.”
  • The paper relies on this without support.

    The periaqueductal gray and insular cortex are involved in pain perception and auditory processing, respectively.

    “The periaqueductal gray and insular cortex are involved in pain perception and auditory processing, respectively.”
  • The paper relies on this without support.

    Lower betweenness centrality indicates fewer traffic hubs and inefficient information routing with fewer direct pathways.

    “Lower betweenness centrality indicates fewer “traffic hubs”, suggesting inefficient information routing with fewer direct pathways.”
  • The paper relies on this without support.

    Previous human studies have shown reduced fractional anisotropy in APOE4 carriers.

    “Previous human studies have shown reduced fractional anisotropy in APOE4 carriers.”
  • The paper relies on this without support.

    The underlying cellular basis for the decrease in fractional anisotropy in APOE4 carriers has been unclear.

    “However, the underlying cellular basis for this decrease in fractional anisotropy has been unclear.”
  • The paper relies on this without support.

    The APOE4 allele is a well-established risk factor for AD.

    “The APOE4 allele is a well‐established risk factor for AD.”
  • The paper relies on this without support.

    The 5xFAD;APOE3/APOE4 mouse model recapitulates the APOE4-associated white matter phenotype observed in clinical studies.

    “we established an Aβ‐amyloidosis mouse model expressing either APOE3 or APOE4, recapitulating the APOE4‐associated white matter phenotype observed in clinical studies while enabling mechanistic investigation of APOE4‐related white matter impairment.”
16 of 16

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Diffusion MRI resolution does not match the field of view and matrix

    Minor

    A 20 mm field of view divided by 100 pixels gives 0.2 mm, or 200 μm, per pixel-not the stated 150 μm. The other in-plane dimension likewise gives 17.2 mm / 86 pixels = 200 μm.

    Reported 150 · recomputed 0.2

  • Template sample count conflicts with the stated MRI exclusion

    Minor

    The methods say one of 23 mice was excluded from MRI analysis, leaving 11 per genotype, but the results say the MRI-derived template comprised all 23 samples. The text does not explain why the excluded scan was included in the template.

  • Structural MRI resolution does not match the field of view and matrix

    Minor

    A 20 mm field of view divided by 200 pixels gives 0.1 mm, or 100 μm, per pixel-not the stated 75 μm. The other in-plane dimension gives the same discrepancy (17.2 mm / 172 pixels).

    Reported 75 · recomputed 0.1

  • Disrupted network node has conflicting anatomical labels

    Minor

    The results identify a right insular cortex node in the disrupted network, whereas the Figure 4 caption identifies the corresponding listed node as the right inferior colliculus.

4 of 4

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Al‐Amin, M. M., Kim, B., Karahan, H., Tate, M. D., Walsh, S. P., Puntambekar, S. S., Bissel, S. J., Lamb, B. T., Wang, N., & Kim, J.
Affiliations
  • Stark Neurosciences Research Institute Indiana University School of Medicine Indianapolis Indiana USA
  • Indiana University Indianapolis (US)
Corresponding author
Kim, Jungsu
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2025-10
Volume
21
Issue
10
Pages
e70791-e70791
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W4415076428
Cited by
6
References
64
Citations by year
2026: 5 · 2025: 1
FWCI
3.28
Type
journal article
Language
en
Open access
Locations
  • Alzheimer s & Dementia (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • IUScholarWorks (Indiana University) (submittedVersion, cc-by)
  • Europe PMC (PubMed Central) (submittedVersion, cc-by)
Funders
  • Indiana University
  • National Institutes of Health (R01AG077829, R01AG071281, R21AG072738, RF1AG074543)
  • National Institute on Aging (F31AG074673)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced Neuroimaging Techniques and Applications
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
APOE ε4, apolipoprotein E
MeSH terms
Amyloidosis, Animals, Brain, Corpus Callosum, Disease Models, Animal, Humans, Magnetic Resonance Imaging, Mice, Transgenic, Myelin Sheath, Oligodendroglia, Amyloid beta-Peptides, Neurites, Mice, Apolipoprotein E3, Apolipoprotein E4, White Matter

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-11.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-11.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review